US Stocks
/
Summit Therapeutics Inc. Share Price
Summit Therapeutics Inc. Share Price

Summit Therapeutics Inc. Share Price

NASDAQ: SMMT | Large Cap
$17.83
+$0.13 (0.73%) Last updated on 19 Sep, 2026 | 01:30 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Summit Therapeutics Inc. Stock Performance

Open
$17.78
Prev. Close
$17.70
Circuit Range
N/A
Day Range
$17.34 - $17.87
Year Range
$12.07 - $29.21
Volume
2,19,045
Average Traded
$17.60

Summit Therapeutics Inc. Share Price Today

As of 19 September 2026, Summit Therapeutics Inc.'s share price is $17.83. The stock opened at $17.78, compared to its previous close of $17.70. During today's trading session, Summit Therapeutics Inc.'s share price traded between $17.34 and $17.87, with an average price of $17.61. Over the past 52 weeks, the stock has recorded a high of $29.21 and a low of $12.07. In terms of performance, Summit Therapeutics Inc.'s share price has declined by 5.91% over the last six months and is down 13.70% on a year-on-year basis.

Summit Therapeutics Inc. Share Price Chart

$17.34$17.87
L
Show Current Price
H

Summit Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$13.33B
PE Ratio (TTM)
-12.38
Dividend Yield
N/A
EPS (TTM)
$-1.44
Revenue (TTM)
N/A
Return On Equity (TTM)
-163.86%
Profit Margin
N/A
Debt to Equity
0.11
Quarterly Earnings Growth YoY
N/A

Summit Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2024
Revenue$0.00
Net Profit-$56.25M
Net Profit MarginN/A
Income ChangeN/A

Summit Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars20232024
Revenue$0.00$0.00
Net Profit-$614.93M-$221.31M
Net Profit MarginN/AN/A
Income ChangeN/A64.01%

About Summit Therapeutics Inc.

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.

Summit Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$13.47
$17.86
+24.55%
Aug 2026
$13.07
$14.34
+10.14%
Jul 2026
$14.54
$13.02
-10.64%
Jun 2026
$16.72
$14.57
-16.89%
May 2026
$16.02
$17.53
-18.33%
Apr 2026
$19.17
$21.46
+13.27%
Mar 2026
$16.16
$18.95
+14.16%
Feb 2026
$14.24
$16.60
+14.72%
Jan 2026
$17.66
$14.47
-17.29%
Dec 2025
$17.36
$17.50
-2.15%
Nov 2025
$18.86
$17.88
-5.40%
Oct 2025
$20.75
$18.90
-8.52%

SMMT Share Price FAQs

What is Summit Therapeutics Inc. share price today?

chevron-up
Summit Therapeutics Inc. share price today is $17.83 as on September 19, 2026 at 1:30 am IST.

What is the 52 week high and 52 week low of Summit Therapeutics Inc. stock?

chevron-up
The 52 week high of Summit Therapeutics Inc. stock is $29.21, while the 52 week low is $12.07 as of 19 Sep '26.

What is SMMT's market capitalisation today?

chevron-up
SMMT market capitalisation is $13.33B as of September 19, 2026, at 4:39 pm IST.

What is SMMT's net income for the last quarter?

chevron-up
SMMT's net income for the last quarter is -0.06B USD.

What is the 5 year returns of SMMT?

chevron-up
The 5 year returns of SMMT is 255.89% as on 19 Sep '26.

What is the high & low stock price of SMMT today?

chevron-up
SMMT stock price hit a high of $17.87 and low of $17.34 as of 19 Sep '26.

Can I buy SMMT shares in India?

chevron-up
Yes. You can buy SMMT in India by opening an international trading account.